Investor's Business Daily94d agoneutral
Why This Biotech Dealmaker - Tied To Merck, Travere - Charged HigherNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
102last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
The Wall Street Journal94d agoneutral
Germany’s Merck KGaA Raises Outlook on Robust Results, Easing Currency HeadwindsBioPharma Dive95d agoneutral
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launchGuruFocus.com96d agoneutral
Merck & Co Inc (MRK) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...Barrons.com96d agoneutral
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger StoryReuters96d agoneutral
Merck posts better-than-expected second-quarter results on Keytruda strengthInvestorsHub96d agoneutral
Merck Shares Advance After Strong Second-Quarter Earnings and Higher Revenue OutlookThe Wall Street Journal96d agobearish
Merck Cuts Full-Year Profit Forecast as Acquisition Costs Weigh on Bottom LineInvestor's Business Daily96d agoneutral
The Merck Product That Absolutely Demolished Wall Street's Forecasts